Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 7—July 2024
Research Letter

Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023–2024

Sophie Edouard, Housni Boughammoura, Philippe Colson, Bernard La Scola, Pierre-Edouard Fournier, and Florence FenollarComments to Author 
Author affiliations: IHU–Méditerranée Infection, Marseille, France (S. Edouard, H. Boughammoura, P. Colson, B. La Scola, P.-E. Fournier, F. Fenollar); Aix-Marseille Université, Marseille (S. Edouard, P. Colson, B. La Scola, P.-E. Fournier, F. Fenollar)

Main Article

Table

Demographic characteristics of 449 patients who had Mycoplasma pneumoniae infection diagnosed using quantitative PCR, Marseille, France, 2014–2022 versus 2023–2024*

Characteristic Total
2014–2022
2023–2024
p value
No. patients
449
231
218

Sex
M 258 (57) 137 (59) 121 (56) 0.41
F
191 (43)
94 (41)
97 (44)
Median age, y (range)
10 (0–101)
15 (0–93)
8 (0–101)
<0.001
Age group, y
0–4 117 (26) 50 (22) 67 (31) 0.028
5–14 146 (32) 63 (27) 83 (38) 0.015
15–44 106 (24) 67 (29) 39 (18) 0.006
45–64 40 (9) 29 (13) 11 (5) 0.005
>65
40 (9)
22 (9)
18 (8)
0.638
Co-infections
No. patients tested 316 164 152
No. patients with co-infection 114 (36) 45 (27) 69 (45) 0.0008
With 1 pathogen 94 (82) 41 (91) 53 (77) 0.049
With >2 pathogens 20 (17) 4 (9) 16 (23)
Median age, y (range) 4 (0–101) 7 (0–86) 3 (0–101) 0.012
Age group, y
0–4 58 (51) 18 (40) 40 (58) <0.001
5–14 27 (24) 7 (16) 20 (29) 0.005
15–44 13 (11) 10 (22) 3 (4) 0.089
45–64 8 (7) 6 (13) 2 (3) 0.286
>65 8 (7)
4 (9)
4 (6)
1

*Values are no. (%) except as indicated.

Main Article

Page created: May 23, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external